Unknown

Dataset Information

Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development.


ABSTRACT:

Background & aims

Non-alcoholic steatohepatitis (NASH), a subtype of non-alcoholic fatty liver disease (NAFLD) that can lead to fibrosis, cirrhosis, and hepatocellular carcinoma, is characterized by hepatic inflammation. Despite evolving therapies aimed to ameliorate inflammation in NASH, the transcriptional changes that lead to inflammation progression in NAFLD remain poorly understood. The aim of this pilot study was to define transcriptional changes in early, non-fibrotic NAFLD using two independent biopsy-proven NAFLD cohorts.

Methods

We extracted RNA from liver tissue of 40 patients with biopsy-proven NAFLD based on NAFLD Activity Score (NAS) (23 patients with NAS ≤3, 17 with NAS ≥5) and 21 healthy controls, and we compared changes in expression of 594 genes involved in

SUBMITTER: Kriss M 

PROVIDER: S-EPMC7392333 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature